Nephrogenic Systemic Fibrosis: Suspected Causative Role of Gadodiamide Used for Contrast-Enhanced Magnetic Resonance Imaging (Q22065113)

From Wikidata
Jump to navigation Jump to search
scientific article
  • Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging
edit
Language Label Description Also known as
English
Nephrogenic Systemic Fibrosis: Suspected Causative Role of Gadodiamide Used for Contrast-Enhanced Magnetic Resonance Imaging
scientific article
  • Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging

Statements

Nephrogenic Systemic Fibrosis: Suspected Causative Role of Gadodiamide Used for Contrast-Enhanced Magnetic Resonance Imaging (English)
0 references
P. Marckmann
1 reference
Kristian Rossen
1 reference
Anders Dupont
1 reference
Mette Brimnes Damholt
1 reference
James Goya Heaf
1 reference
Henrik S Thomsen
1 reference
9 August 2006
0 references
17
0 references
9
0 references
2359-2362
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit